Editor's Pick

A year ago today, our youngest child died, thanks to the adversarial actions and toxic treatments foisted on her by medical-model psychiatry. By telling her story, we hope to promote systemic change.

An interview with Elisa Lacerda-Vandenborn about the consequences \psychology and mental health treatment can have for indigenous children.

A Vermont residential community program helps people taper or stay off medications with holistic care embedded in a pastoral setting.

Nassir Ghaemi: “Most psychiatric medications are purely symptomatic, with no known or proven effect on the underlying disease. They are like 50 variations of aspirin, used for fever or headache, rather than drugs that treat the causes of fever or headache.”

A dialogue between Dr. Jim Phelps—a psychiatrist who questions whether MIA is doing more harm than good by reporting the results of long-term trials of psychiatric drugs—and Robert Whitaker, founder of MIA.

My brother’s sudden death and Mental Health Awareness Month spurred me to spend May making small, very personal efforts to both honor his memory and move the mental health conversation forward.

Paula Caplan, known for her fierce criticism of psychiatry and its diagnostic manual, died Wednesday at age 74.

Sharing the similarities between Lindsay Clancy's homicidal episode and my own will hopefully help prevent rare SSRI-induced suicides and homicides, including mass shootings.

As some of us get caught up in lamenting the whiteness of our movement, we are actively losing the stories of Black leaders.

"I see the white paper as the culmination of my 40+ years of advocacy for people subjected to psychiatric incarceration and forced drugging."

Why does the U.S. describe perinatal screening as providing a proven benefit, while the task forces in the U.K. and Canada see no evidence of such benefit?

Amid growing mental health crisis, research raises questions about the mass rollout of brief psychotherapies in Australia.

On May 26, MindFreedom will partner with “I Love You, Lead On” to host the fifth in an educational series to create cross-disability understanding of common themes and initiatives.

Those struggling with suicidal thoughts may stay silent instead of reaching out to suicide hotlines because they fear non-consensual intervention and the harmful impact of police involvement.

Loss, grief, and betrayal are felt deeply by many who have been affected by the myth of the chemical imbalance, especially now that it has been debunked.

Preying on the privatisation of distress comes the medical-industrial complex perverting the mental health landscape.

Do we take enough account of total drug exposure time when devising antidepressant tapering strategies?

A dialogue between Jim Phelps and Robert Whitaker about Nassir Ghaemi's latest article, which concluded that psychiatric drugs, except for lithium, do not provide a long-term benefit.

We talk with Dr. Michael Hengartner about his new book which addresses the overprescribing of antidepressant drugs and critically examines the scientific evidence on their efficacy and safety.

We interview Ole Andreas Underland, Director of the Hurdalsjøen Recovery Center in Norway which provides “medication-free” care for those who want such treatment or who want to taper from their psychiatric drugs. Ole Andreas explains why the success of this pioneering approach might threaten its future.

Risk of depression increased when children were taking methylphenidate for ADHD, but once they stopped taking the drug, depression risk dropped to normal levels.

Ayurdhi Dhar interviews Erick Turner about publication bias in antidepressant trials, compromised psychotherapeutic research, and a culture of journal worship.

Researchers question the long-term use of antipsychotics and suggest increased research and investment in psychosocial interventions.

Celia Brown, Ron Bassman, and Peter Stastny mourn the loss of Darby Penney, who fought to transform the mental health system in New York.

Hanna Pickard on the elusive middle ground between personal responsibility and systemic factors in our understandings of addiction.